At the 2016 ACR/ARHP Annual Meeting, Tatsuo Nagai proposed that the expression of S100A9 and S100A12 mRNA in RA BM CD34+ cells was significantly higher than that in OA BM CD34+ cells. This evidence concerns the gene CD34 and rheumatoid arthritis.